Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBASPHERE vs RIFAPENTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBASPHERE vs RIFAPENTINE: Safety Overview

Metric RIBASPHERE RIFAPENTINE
Total FAERS Reports 123 298
Deaths Reported 2 8
Death Rate 1.6% 2.7%
Hospitalizations 19 88
Average Patient Age 55.6 yrs 46.5 yrs
% Female Patients N/A 55.6%
FDA Approval Date N/A Jun 22, 1998
Manufacturer N/A sanofi-aventis U.S. LLC
Route N/A ORAL
Marketing Status N/A Prescription